Go to page
 

Bibliographic Metadata

Title
Serum anti-Müllerian hormone levels in obese and non-obese women with polycystic ovary syndrome under clomiphene citrate stimulation / submitted by Dr. scient. med. Luna Wattar
Additional Titles
Der Serum Anti-Müller Hormon-Spiegel bei adipösen und nicht adipösen Frauen mit Polyzystischem Ovarialsyndrom unter Clomifen Citrat Stimulation
AuthorWattar, Luna
Thesis advisorHuber, Johannes
PublishedWien, 01.2017
DescriptionXII, 72 Blätter : Illustrationen
Institutional NoteMedizinische Universität Wien, Dissertation, 2017
Annotation
Zusammenfassung in deutscher Sprache
Abweichender Titel laut Übersetzung der Verfasserin/des Verfassers
LanguageEnglish
Bibl. ReferenceOeBB
Document typeDissertation (PhD)
Keywords (DE)Anti-Müller Hormon / Clomifen Citrat / das polyzystische Ovar syndrom
Keywords (EN)Anti-Müllerian hormone / Clomiphene Citrate / polycystic ovary syndrome
URNurn:nbn:at:at-ubmuw:1-9595 Persistent Identifier (URN)
Restriction-Information
 The work is publicly available
Files
Serum anti-Müllerian hormone levels in obese and non-obese women with polycystic ovary syndrome under clomiphene citrate stimulation [1.86 mb]
Links
Reference
Classification
Abstract (English)

Background: Polycystic Ovary Syndrome (PCOS) is one of the most common endocrinopathies affecting women in the reproductive age. More than a half of PCOS patients are overweight or obese. Patients with PCOS have increased levels of anti-Müllerian hormone (AMH), while AMH decreases in obese women comparing to their lean counterparts.

Objective: To evaluate whether AMH levels differ in obese and non-obese anovulatory women suffering from PCOS under clomiphene citrate (CC) stimulation.

Study population: A total of 63 patients (29 normal weight, 34 overweight-obese with BMI ≥ 25kg/m2) aged 19-35 years, had PCOS according to the Rotterdam criteria, were recruited at the department of Gynecological Endocrinology and Reproductive Medicine of the Medical University of Vienna.

Results: The AMH mean value in the overweight-obese group was lower than that of the normal weight group, but the difference was not statistically significant (6.95 ng/ml vs. 9.39 ng/ml, P= 0.061). A subgroup of 55 patients received 50mg CC to induce ovulation. AMH levels were significantly lower in women who responded to CC in comparison to those who did not ovulate (6.84 ng/ml vs. 9.81 ng/ml; p=0.039). AMH had significantly the lowest mean value in overweight-obese patients who responded to CC (AMH 4.87 ng/ml; P=0.0343). An AMH cut-off value of 7.4 ng/ml had 92.3% sensitivity and 68.7% specificity to predict CC success in overweight-obese women with PCOS.

Conclusion: There was no statistically significant difference in AMH values between obese and non-obese PCOS women. Studying a larger cohort with a standardized BMI classification may lead to different results. Lower AMH values were associated with a successful induction of ovulation with CC.

Stats
The PDF-Document has been downloaded 15 times.